Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.24704 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.12471 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.12714 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.52356 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.06583 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.35677 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.37255 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.21907 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.09244 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.13387 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.12842 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.07247 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.16356 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.25626 | 69 |